CF
AXSM icon

CNA Financial’s Axsome Therapeutics AXSM Stock Holding History

CNA Financial’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,460
Closed -$366K – 198
2021
Q1 		$366K Buy
6,460
+230
+4% +$16.2K 0.11% 179
2020
Q4 		$508K Buy
6,230
+940
+18% +$70.3K 0.16% 157
2020
Q3 		$377K Buy
5,290
+900
+21% +$70.1K 0.14% 156
2020
Q2 		$361K Buy
+4,390
New +$338K 0.14% 157

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

CNA Financial's AXSM Position: Q2 2021 in Review

CNA Financial sold out of Axsome Therapeutics (AXSM) in Q2 2021, closing a stake of 6,460 shares — an estimated $366K sold.

CNA Financial first reported a position in AXSM in Q2 2020 and held it in 4 quarters. The position peaked at $508K in Q4 2020. 176 funds tracked by Wall St. Rank hold AXSM as of Q2 2021.

  • CNA Financial reported no remaining Axsome Therapeutics position as of Q2 2021 after selling out during the quarter.
  • CNA Financial sold 6,460 Axsome Therapeutics shares in Q2 2021, an estimated $366K.
  • CNA Financial first reported a position in Axsome Therapeutics in Q2 2020 and held it in 4 quarters.
  • CNA Financial's Axsome Therapeutics position peaked at $508K in Q4 2020.
  • 176 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2021.

Based on CNA Financial's 13F filing for Q2 2021, filed 12 Aug 2021.